Accès ouvert
2021
article
OpenAlex
François Danion, Céline Duval, François Séverac, Philippe Bachellier et autres
OBJECTIVES: To describe the coinfections in invasive aspergillosis (IA), to identify factors associated with coinfections, and to evaluate the impact of coinfection on mortality. PATIENTS AND METHODS: We conducted a monocentric retrospective study of consecutive putative, probable, or proven IA that occurred …
fr
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Sylvain Lescuyer, Marie‐Pierre Ledoux, Simon Gravier, Shanti Natarajan‐Amé et autres
Ruxolitinib is a JAK-1/JAK-2 inhibitor indicated for the treatment of polycythemia vera and primary or secondary myelofibrosis. Only one patient (0.2%) was diagnosed with tuberculosis among the 485 patients receiving ruxolitinib in the four pivotal trials. Fourteen cases of tuberculosis have since …
fr
(code pays fourni par la source)
2011
article
OpenAlex
Céline Duval, Sophie Caillard, Peggy Perrin, Jérôme Olagne et autres
fr
(code pays fourni par la source)
Accès ouvert
1999
article
OpenAlex
Bernard Paillot, Pierre Czernichow, Pierre Michel, V. Merle et autres
BACKGROUND: Subjects without known colorectal adenomas or cancer constitute a large majority of the population where 85% of all cases of colorectal cancer are thought to occur. Consequently these people should be considered for screening to decrease mortality from colorectal cancer in …
fr
(code pays fourni par la source)